Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.
Filter Awards
| Disease | Cell Type |
Therapeutic or Technology |
Institution | Stage | Project Objective | Details |
|---|---|---|---|---|---|---|
| Multiple Myeloma | Adult Stem Cell | UCLA |
 |
Pre-IND/IDE or Equivalent | ||
|
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Antibody | Stanford |
 |
Clinical Trial, Phase 1 or Phase 1/2 | |
| Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | UCSD |
 |
Development Candidate, Proof of Concept | |
| Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Cellerant Therapeutics |
 |
IND | |
|
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | COH |
|
Development Candidate, Proof of Concept | |
| Colon Cancer | Cancer Stem Cell | Antibody | Forty Seven |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Severe Combined Immunodeficiency, X-linked (X-SCID) | Adult Stem Cell | Antibody | Stanford |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Forty Seven |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Vascular Disease | Adult Stem Cell | Biologic | UCSD |
|
Pre-IND/IDE or Equivalent | |
| Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
|
Pre-IND/IDE or Equivalent | |
| Kidney Failure | Adult Stem Cell | Biologic | Humacyte |
 |
Clinical Trial, Phase 3 | |
| Kidney Failure | Adult Stem Cell | Biologic | Humacyte |
|
Clinical Trial, Phase 3 | |
|
Amyotrophic Lateral Sclerosis, Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Cell imaging & tracking | UCSD |
|
Research Insights | |
| Other | Embryonic Stem Cell | Cell imaging & tracking | UC Berkeley |
|
Tool/Resources/Bottleneck | |
| Vision Loss | iPS Cell | Cell processing & handling | UCSD |
|
Tool/Resources/Bottleneck | |
| Other |
Embryonic Stem Cell, iPS Cell |
Cell processing & handling | X-Therma |
|
Proof of Concept, Tool/Resources/Bottleneck | |
|
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
|
Regulated Lab Test, Ready for Validation | |
| Liver Disease | Embryonic Stem Cell | Donor cell therapy | Stanford |
|
Development Candidate, Proof of Concept | |
|
Bladder or Urinary Tract Disorder, Solid Tumors |
Embryonic Stem Cell | Donor cell therapy | Stanford |
|
Development Candidate, Proof of Concept | |
| Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | jCyte |
 |
Clinical Trial, Phase 2 | |
| Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
|
Pre-IND/IDE or Equivalent | |
| Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Blood Cancer, Bone Marrow Transplant and Viral Infection |
Adult Stem Cell | Donor cell therapy | CHLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Stroke | iPS Cell | Donor cell therapy | UCLA |
|
Development Candidate | |
| Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
|
Development Candidate | |
| Heart Disease | Embryonic Stem Cell | Donor cell therapy | Stanford |
|
IND | |
| Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
|
IND | |
| Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
|
Pre-IND/IDE or Equivalent | |
| Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | UCSF |
|
Development Candidate | |
| Bone or Cartilage Disease | Embryonic Stem Cell | Donor cell therapy | USC |
|
Pre-IND/IDE or Equivalent | |
| Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | UCSD |
|
Pre-IND/IDE or Equivalent | |
| Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
|
Pre-IND/IDE or Equivalent | |
| Spinal Cord Injury | Adult Stem Cell | Donor cell therapy | UC Irvine |
|
Development Candidate | |
| Age-related macular degeneration | Adult Stem Cell | Donor cell therapy | Stanford |
|
Pre-IND/IDE or Equivalent | |
| Brain Injury, hypoxic, ischemic | Adult Stem Cell | Donor cell therapy | Sanford-Burnham |
|
Pre-IND/IDE or Equivalent | |
| Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
|
Clinical Trial, Phase 3 | |
|
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
|
IND | |
| Bone or Cartilage Disease | iPS Cell | Donor cell therapy | Cedars-Sinai |
|
Proof of Concept, Research Insights | |
| Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | Lineage Cell |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Thymic Disorder, 22q11 Deletion/DiGeorge |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Stanford |
|
Development Candidate, Proof of Concept | |
| Blood Cancer | Adult Stem Cell | Donor cell therapy | Angiocrine |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Retinitis Pigmentosa | Donor cell therapy | jCyte |
|
Clinical Trial, Phase 2 | ||
| Bone or Cartilage Disease | Adult Stem Cell | Donor cell therapy | UCLA |
|
Proof of Concept | |
| Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
|
IND | |
| Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
|
Clinical Trial, Phase 1 or Phase 1/2 |
Pages
